BARY KEMBLE: Open Payments
NPI 1356032072 · PAWLEYS ISLAND, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$210 in 12 payments from 7 companies in 2025. Trend: 2023 $46 · 2024 $263 · 2025 $210
Food & beverage: $210
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Novo Nordisk Inc | 2 | $40 |
| ABBVIE INC. | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $28 |
| Corcept Therapeutics | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $16 |
Products named: AIRSUPRA, XIFAXAN, Korlym, Ozempic, INJECTAFER, FARXIGA, Rybelsus, QULIPTA.
Industry payments across SC — which companies pay providers there.
